CSPCY (CSPC Pharmaceutical Group) Tariff Resilience Score: 4/10 (As of Jul. 04, 2026)


CSPCY CSPC Pharmaceutical Group Ltd CSPCY
78 GF Score
Price $3.84
GF Value $3.16
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Tariff Resilience Score?

CSPC Pharmaceutical Group CSPCY +8.17% 78 Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus rates CSPCY with a GF Score™ of 78/100 and a GF Value™ of $3.16 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,030 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 79.9% on this metric.

CSPC Pharmaceutical Group has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

CSPC Pharmaceutical Group has CSPC Pharmaceutical is vulnerable to tariffs on raw materials and finished goods, especially in the US market. Its global supply chain and export focus increase risk. Previous tariffs have affected costs, with limited pricing power to offset impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes CSPC Pharmaceutical Group might have Average Resilient.

CSPC Pharmaceutical Group  (OTCPK:CSPCY) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

CSPC Pharmaceutical Group Tariff Resilience Score Related Terms

CSPCY vs LLY, JNJ, ABBV: Tariff Resilience Score Comparison

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Tariff Resilience Score falls into.


CSPCY
78GF Score
CSPC Pharmaceutical Group Ltd CSPCY
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
CSPC Pharmaceutical Group (CSPCY) has a Tariff Resilience Score of 4 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #207 out of 1030 companies in the Drug Manufacturers industry, placing it in the top 20.1%.
Is CSPC Pharmaceutical Group's Tariff Resilience Score too high?
CSPC Pharmaceutical Group's current Tariff Resilience Score is 4. Based on the distribution chart, CSPC Pharmaceutical Group ranks #207 out of 1030 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, CSPC Pharmaceutical Group has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Tariff Resilience Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #207 out of 1030 companies for Tariff Resilience Score. This places CSPC Pharmaceutical Group in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. CSPC Pharmaceutical Group's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.16, compared to a current price of $3.84 — trading 21.5% above its estimated fair value. The current Tariff Resilience Score is 4. CSPC Pharmaceutical Group's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Tariff Resilience Score is 4 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of $3.84 is trading 21.5% above its estimated GF Value™ of $3.16. GuruFocus considers CSPC Pharmaceutical Group to be Modestly Overvalued.

Key valuation signals for CSPCY:

  • Tariff Resilience Score: 4
  • GF Value™: $3.16 vs. price of $3.84 (21.5% above fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
78GF Score

Get the complete analysis for CSPCY

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84
Price
$3.16
GF Value